Franklin Genomic Advancements ETFHELX
- AUM
- $35M
- Fee
- 0.50%
- Yield
- 0.3%
- Bumpy · 1Y
- 1.8×S&P
- Volume
- 371
- NAV
- $44.03
52-week range9% below the high
$31.24$46.22
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −3.2% | −1.1% | +1.8% | +16.2% | +21.8% | +61.8% | −21.1% | +77.4% |
| Peer average | +2.4% | +2.8% | +6.4% | +5.5% | +23.4% | +33.1% | +76.7% | +28.9% | — |
| S&P 500 · VOO | +2.3% | +0.1% | −3.3% | −2.1% | +11.3% | +13.6% | +81.6% | +75.4% | — |
HELX in One Breath
HELX Among Health Care ETFs
YTDEnd-of-day Nov 10, 2026 · 33 Health care ETFs by YTD
$10,000 in HELX
5Y$10,000 in HELX became
$7,892
In the S&P 500 (VOO)
$17,543
Total return, dividends in · Nov 1, 2021 – Nov 9, 2026 · S&P 500 uses VOO
HELX’s Top Holdings
TodayGHGuardant Health8.7%NTRA8.1%ADPT4.9%KRYS4.8%LGND4.6%TWST3.5%BBIO3.3%MEDP2.9%VRTX2.9%LLY2.7%UTHR2.7%REGN2.5%TVTX2.4%VYLR2.2%CDNA2.1%TEM2.1%RGEN2.0%GRAL1.8%CRL1.8%NBIXARGX.JAZZ41 more
GHGuardant Health8.7%NTRA8.1%ADPT4.9%KRYS4.8%LGND4.6%TWST3.5%BBIO3.3%MEDP2.9%VRTX2.9%LLY2.7%UTHR2.7%51 more
BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - Healthcare Information ServicesMedical - InstrumentsAgricultural Inputs
Franklin Templeton HELX · 63 holdings · tile size = share of the fund · as of Nov 9, 2026
What HELX Holds
TodayBiotechnology53.5%
ADPT 4.9 · KRYS 4.8 · LGND 4.6 · TWST 3.5 · BBIO 3.3 · VRTX 2.9 · UTHR 2.7
Medical - Diagnostics & Research29.5%
GH 8.7 · NTRA 8.1 · MEDP 2.9 · CDNA 2.1 · GRAL 1.8 · CRL 1.8 · IQV 1.1
Drug Manufacturers - General3.3%
LLY 2.7 · AZN.L
Medical - Healthcare Information Services3.2%
TEM 2.1 · HNGE 1.1
Medical - Instruments & Supplies2.9%
RGEN 2.0 · SRT3.DE
Agricultural Inputs2.5%
VYLR 2.2 · CTVA
Medical - Pharmaceuticals2.4%
KNSA 1.2 · RPRX 1.1 · LQDA
Franklin Templeton HELX · share of the fund by industry · as of Nov 9, 2026
Guardant’s Share of HELX
Today8.7%
$87 of every $1,000 in HELX is Guardant
Guardant held by HELX
$3.0M
Franklin Templeton HELX · each square = $10 of $1,000 · as of Nov 9, 2026
HELX’s Share of Health Care ETFs
Today0.0%
of the $110B in 39 Health care ETFs
$35.2M0.0%
$49.7B45.0%
$19.1B17.3%
$41.6B37.7%
Health care ETF AUM · Nov 10, 2026
HELX Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 10, 2026
Inside HELX
63 holdings · as of Nov 9, 2026HELX
Franklin Genomic Advancements ETF
TodayBiotechnology53.5%ADPT4.9%KRYS4.8%LGND4.6%TWST3.5%BBIO3.3%VRTX2.9%UTHR2.7%REGN2.5%TVTX2.4%NBIX1.7%ARGX.BJAZZPTCT24 more holdings15.1% of the fundMedical - Diagnostics29.5%GH8.7%NTRA8.1%MEDP2.9%CDNA2.1%GRAL1.8%CRL1.8%IQVTMOAQIA.DVCYTDrug Manufacturers - General3.3%LLYMedical - Healthcare Information Services3.2%TEM2.1%HNGEMedical - Instruments2.9%RGENSRT3.DAgricultural Inputs2.5%VYLR2.2%Medical - Pharmaceuticals2.4%KNSARPRXGKOSBIOETONCDNS
Biotechnology53.5%ADPT4.9%KRYS4.8%LGND4.6%TWST3.5%BBIO3.3%VRTX2.9%32 more holdings29.5% of the fundMedical - Diagnostics29.5%GH8.7%NTRA8.1%MEDPCDNAGRALCRL6 moreDrug Manufacturers - General3.3%LLYMedical - Healthcare Information Services3.2%TEMMedical - Instruments2.9%RGENVYLRMedical - Pharmaceuticals2.4%KNSARPRXETON
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GH | Guardant Health | 8.65% |
| 2 | NTRA | Natera | 8.08% |
| 3 | ADPT | Adaptive Biotechnologies | 4.92% |
| 4 | KRYS | Krystal Biotech | 4.85% |
| 5 | LGND | Ligand Pharmaceuticals | 4.61% |
| 6 | TWST | Twist Bioscience | 3.46% |
| 7 | BBIO | Bridgebio Pharma | 3.30% |
| 8 | MEDP | Medpace | 2.92% |
| 9 | VRTX | Vertex Pharmaceuticals IN | 2.86% |
| 10 | LLY | ELI Lilly & | 2.75% |
BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - Healthcare Information ServicesMedical - InstrumentsAgricultural InputsMedical - PharmaceuticalsMedical - DevicesDrug Manufacturers - SpecialtySoftware - ApplicationOther
Franklin Templeton HELX · current holdings by weight · as of Nov 9, 2026 · each tile is one holding · top 20 = 67.7%
All HELX Holdings
71 holdings · as of Nov 9, 2026HELX
HELX’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GHGuardant Health | Healthcare | 8.65% | $865.05 | 19K | $2.9M |
| 2 | NTRANatera | Healthcare | 8.08% | $808.01 | 8,775 | $2.7M |
| 3 | ADPTAdaptive Biotechnologies | Healthcare | 4.92% | $492.43 | 59K | $1.7M |
| 4 | KRYSKrystal Biotech | Healthcare | 4.85% | $484.69 | 5,435 | $1.6M |
| 5 | LGNDLigand Pharmaceuticals | Healthcare | 4.61% | $461.49 | 5,085 | $1.6M |
| 6 | TWSTTwist Bioscience | Healthcare | 3.46% | $346.31 | 9,673 | $1.2M |
| 7 | BBIOBridgebio Pharma | Healthcare | 3.30% | $330.35 | 15K | $1.1M |
| 8 | MEDPMedpace | Healthcare | 2.92% | $292.11 | 1,509 | $986K |
| 9 | VRTXVertex Pharmaceuticals IN | Healthcare | 2.86% | $286.20 | 1,765 | $966K |
| 10 | LLYELI Lilly | Healthcare | 2.75% | $274.90 | 685 | $927K |
| 11 | UTHRUnited Therapeutics | Healthcare | 2.72% | $272.19 | 1,634 | $918K |
| 12 | REGNRegeneron Pharmaceuticals | Healthcare | 2.46% | $246.33 | 919 | $831K |
| 13 | TVTXTravere Therapeutics | Healthcare | 2.38% | $237.61 | 16K | $802K |
| 14 | VYLRVylor | Basic Materials | 2.17% | $217.31 | 10K | $733K |
| 15 | CDNACaredx | Healthcare | 2.13% | $212.87 | 9,142 | $718K |
Franklin Templeton HELX · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 9, 2026
How It Compares
HELX
Franklin Genomic Advancements ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 10, 2026 · sorted by AUM
Head to Head
Put HELX head to head with XLV →XLV vs HELX
YTDYear to date
XLV wins+7.0 pts
Past year
XLV wins+9.4 pts
Fee
XLV winslower fee
Yield
XLV wins+1.0 pt
AUM
XLV1410.5× more
4–0XLV wins
SPDR XLV and Franklin Templeton HELX · year-to-date · as of Nov 10, 2026 · AUM not scored
HELX vs VOO
YTDHELX · Franklin Genomic Advancements
+16.2%
VOO · S&P 500
+11.3%
Gap
4.9 pts
Franklin Templeton HELX and Vanguard VOO · YTD total return · as of Nov 10, 2026
HELX vs Its Peer Average
YTDHELXAvsBPeer average
1D0.0%+2.4%
1M−1.1%+6.4%
3M+1.8%+5.5%
YTD+16.2%+23.4%
1Y+21.8%+33.1%
3Y+61.8%+76.7%
5Y−21.1%+28.9%
0–7Peer average wins
38 Health care peers · each row scaled to its leader
How Bumpy Is HELX?
ViewHELX
How Bumpy
1Y1.8×the S&P 500’s swings
CalmerBumpierS&P 1×HELX
Calm rank among 7 health care funds#6
Other health care funds1.2× to 2.2×
Franklin Templeton HELX · daily swings over the past year vs the S&P 500
HELX
Worst Drop
1Y−18.0%from its Jan 22 high
Still below the high−8.3%
$10,000 at the high is now$9,170
Franklin Templeton HELX · fall from the highest close, past year
HELX
On a Bad Day
1Y0.9×the S&P 500’s fall
HELX’s worst day: Thursday, Nov 5Up days51 of every 100
S&P 500 up days52 of every 100
Franklin Templeton HELX · average move on days the S&P 500 fell
HELX
Return for the Bumps
1Y#6 of 7 health care fundsRanked by return above cash for each unit of bumpiness (Sharpe ratio) · cash = 3.8%
HELX
Cost
Today$50a year per $10,000
Expense ratio 0.50%, taken from the fund’s value
HELX
Volatility & Beta
1Y25.3%annual volatility
S&P 500 volatility13.7%
Downside volatility17.4%
Beta vs SPY0.98
Correlation vs SPY0.53
Beta rank, lowest first, of 7#6
Daily total returns × √252 · past 254 trading days
HELX
Max Drawdown
1Y−18.0%peak to trough
Peak closeJan 22, 2026
Current drawdown−8.3%
Worst day−6.29% · Nov 5
Closing prices, dividends in
HELX
Up / Down Capture
1Y92%down capture vs SPY
Up ÷ down capture1.13
Up days51.2% (S&P 52.4%)
Average daily move on SPY up days and down days
HELX
Sharpe & Sortino vs Peers
1YSharpe = (return − 3.8% cash) ÷ volatility · Sortino uses downside volatility only
HELX
Trading
Today−4.17%below its holdings’ value
Close$42.19
NAV$44.03
Fee per $10,000$50 a year
Avg. volume 30D11K shares
Close vs net asset value, Nov 9
The Details
HELX
Fund Facts
Today2020launched Feb 25
Tracks[…]
Exchange · CUSIPCBOE · 35473P520
StructureETF
Leverage1x
Cost on $10,000$50 a year
Go deeper
Franklin Templeton HELX · fund facts · as of Nov 10, 2026
HELX
Payouts by Year
3Y$0.14per share, Dec 2025
Distribution yield0.3%
PaidOnce a year, in December
Latest ex-date · paidDec 30 · Jan 8, 2026
4 payouts added up$0.31 a share
Franklin Templeton HELX · distributions by ex-date · 2020–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗SEC reported portfolio · 2025-06-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-03-31 ↗
Trading & Liquidity
Net asset value$44.03
Premium / discount[…]
Median spread · 30D[…]
Volume today371
Average volume · 30D11K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.50%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$50.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Jan 8, 2026 | $0.14 |
| Dec 30, 2021 | Jan 7, 2022 | $0.0040 |
| Dec 13, 2021 | Dec 21, 2021 | $0.11 |
| Dec 14, 2020 | Dec 23, 2020 | $0.0520 |
Issuer contentFrom Franklin TempletonHear the strategy from the people behind HELX.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →